29
70
Growth Score 29 in past quarter
7 pts
Heat Score 70 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
295479
Stark Therapeutics is a preclinical stage biotechnology company.
About the Company
Stark Therapeutics is a manufacturer of various therapies based on the adeno-associated viral-based gene for chronic diseases such as type II diabetes. The company's therapies employ a non-pathogenic virus known as Adeno-Associated Virus to deliver DNA to specific tissues in the body, allowing patients to receive advanced treatment in
diagnosing various diseases.